TY - JOUR
T1 - Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
AU - Advanced Imaging for Glaucoma Study Group
AU - Zhang, Xinbo
AU - Loewen, Nils
AU - Tan, Ou
AU - Greenfield, David S.
AU - Schuman, Joel S.
AU - Varma, Rohit
AU - Huang, David
AU - Francis, Brian
AU - Parrish, Richard K.
AU - Kishor, Krishna S.
AU - Quinn, Carolyn D.
AU - Iverson, Shawn
AU - Kish, Nayara
AU - Rebimbas, Jose
AU - Weiss, Debra
AU - Chopra, Vikas
AU - Gil-Flamer, John
AU - Linton, Judith
AU - Ramos, Sylvia
AU - Albeiruti, Eiyass
AU - Noecker, Robert
AU - Derosa, Michael
AU - Owens, Greg
AU - Salay, Melessa
AU - Truman, Kristy
AU - Ladwig, Janice
AU - Montalto, Michelle
AU - Ishikawa, Hiroshi
AU - Kagemann, Larry
AU - Sehi, Mitra
AU - Wang, Yimin
AU - Wollstein, Gadi
AU - Bi, Sharon
AU - Chakraborty, Swati
AU - Dilaura, Robert
AU - Hu, Bo
AU - Sell, John
AU - Savatovsky, Eleonore
AU - Sadda, Srinivas R.
AU - Konduru, Ranjith
AU - Rakhshan, Elnaz
AU - Srinivas, Sowmya
AU - Lu, Ake T.H.
N1 - Funding Information:
Funding/Support: Supported by NIH Grant R01-EY013516-Advanced Imaging in Glaucoma Study, NIH Grant R01-EY023285- Functional and Structural Optical Coherence Tomography for Glaucoma, and an unrestricted grant from Research to Prevent Blindness. Dr. Nils Lowen contributed greatly by providing writing support. Financial disclosures: David Huang and Ou Tan have a significant financial interest in Carl Zeiss Meditec, Inc (Dublin, California). Oregon Health & Science University (OHSU, Portland, Oregon), David Huang, and Ou Tan have a significant financial interest in Optovue, Inc (Fremont, California), a company that may have a commercial interest in the results of this research and technology. These potential conflicts of interest have been reviewed and managed by OHSU. David Huang and Joel S. Schuman receive royalties for an optical coherence tomography patent owned and licensed by the Massachusetts Institute of Technology (Cambridge, Massachusetts) and Massachusetts Eye & Ear Infirmary to Carl Zeiss Meditec Inc. David S. Greenfield receives research support from Optovue, Inc, Carl Zeiss Meditec, Inc, and Heidelberg Engineering (Carlsbad, California). Rohit Varma has received research grants, honoraria, and/or travel support from Carl Zeiss Meditec, Inc, Heidelberg Engineering, and Optovue, Inc. The following authors have no financial disclosures: Xinbo Zhang and Nils Loewen. All authors attest that they meet the current ICMJE criteria for authorship.
Publisher Copyright:
© 2016 Elsevier Inc. All rights reserved.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Purpose To predict the development of glaucomatous visual field (VF) defects using Fourier-domain optical coherence tomography (FD OCT) measurements at baseline visit. Design Multicenter longitudinal observational study. Glaucoma suspects and preperimetric glaucoma participants in the Advanced Imaging for Glaucoma Study. Methods The optic disc, peripapillary retinal nerve fiber layer (NFL), and macular ganglion cell complex (GCC) were imaged with FD OCT. VF was assessed every 6 months. Conversion to perimetric glaucoma was defined by VF pattern standard deviation (PSD) or glaucoma hemifield test (GHT) outside normal limits on 3 consecutive tests. Hazard ratios were calculated with the Cox proportional hazard model. Predictive accuracy was measured by the area under the receiver operating characteristic curve (AUC). Results Of 513 eyes (309 participants), 55 eyes (46 participants) experienced VF conversion during 41 ± 23 months of follow-up. Significant (P <.05, Cox regression) FD OCT risk factors included all GCC, NFL, and disc variables, except for horizontal cup-to-disc ratio. GCC focal loss volume (FLV) was the best single predictor of conversion (AUC = 0.753, P <.001 for test against AUC = 0.5). Those with borderline or abnormal GCC-FLV had a 4-fold increase in conversion risk after 6 years (Kaplan-Meier). Optimal prediction of conversion was obtained using the glaucoma composite conversion index (GCCI) based on a multivariate Cox regression model that included GCC-FLV, inferior NFL quadrant thickness, age, and VF PSD. GCCI significantly improved predictive accuracy (AUC = 0.783) over any single variable (P =.04). Conclusions Reductions in NFL and GCC thickness can predict the development of glaucomatous VF loss in glaucoma suspects and preperimetric glaucoma patients.
AB - Purpose To predict the development of glaucomatous visual field (VF) defects using Fourier-domain optical coherence tomography (FD OCT) measurements at baseline visit. Design Multicenter longitudinal observational study. Glaucoma suspects and preperimetric glaucoma participants in the Advanced Imaging for Glaucoma Study. Methods The optic disc, peripapillary retinal nerve fiber layer (NFL), and macular ganglion cell complex (GCC) were imaged with FD OCT. VF was assessed every 6 months. Conversion to perimetric glaucoma was defined by VF pattern standard deviation (PSD) or glaucoma hemifield test (GHT) outside normal limits on 3 consecutive tests. Hazard ratios were calculated with the Cox proportional hazard model. Predictive accuracy was measured by the area under the receiver operating characteristic curve (AUC). Results Of 513 eyes (309 participants), 55 eyes (46 participants) experienced VF conversion during 41 ± 23 months of follow-up. Significant (P <.05, Cox regression) FD OCT risk factors included all GCC, NFL, and disc variables, except for horizontal cup-to-disc ratio. GCC focal loss volume (FLV) was the best single predictor of conversion (AUC = 0.753, P <.001 for test against AUC = 0.5). Those with borderline or abnormal GCC-FLV had a 4-fold increase in conversion risk after 6 years (Kaplan-Meier). Optimal prediction of conversion was obtained using the glaucoma composite conversion index (GCCI) based on a multivariate Cox regression model that included GCC-FLV, inferior NFL quadrant thickness, age, and VF PSD. GCCI significantly improved predictive accuracy (AUC = 0.783) over any single variable (P =.04). Conclusions Reductions in NFL and GCC thickness can predict the development of glaucomatous VF loss in glaucoma suspects and preperimetric glaucoma patients.
UR - http://www.scopus.com/inward/record.url?scp=84959551965&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959551965&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2015.11.029
DO - 10.1016/j.ajo.2015.11.029
M3 - Article
C2 - 26627918
AN - SCOPUS:84959551965
SN - 0002-9394
VL - 163
SP - 29
EP - 37
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -